Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Multicentic to Compare PUVA+IFN Alpha 2a vs PUVA Alone in Mycosis Fungoides Stages Ia, Ib or IIa.

NCT00630903 is registered in ClinicalTrials.gov with Madrilenian Group of Cutaneous Lymphomas as lead sponsor.

NCT NCT00630903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00630903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Multicentic to Compare PUVA+IFN Alpha 2a vs PUVA Alone in Mycosis Fungoides Stages Ia, Ib or IIa.
Lead sponsor
Madrilenian Group of Cutaneous Lymphomas
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2000
Completion date
Not reported
Enrollment
54 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous t-cell lymphoma (mycosis fungoides)